Market

German Pharma-Park Marburg, home to BioNTech, up for sale -sources By Reuters

© Reuters. FILE PHOTO: General view shows the laboratories of BioNTech at their COVID-19 vaccine production facility as the spread of the coronavirus disease (COVID-19) continues, in Marburg, Germany, March 27, 2021. REUTERS/Kai Pfaffenbach/File Photo

FRANKFURT (Reuters) – Pharma-Park Marburg, where German drugmaker BioNTech produces its COVID-19 vaccine, has been put up for sale in a potential 450 million euro ($531 million) deal, three people close to the matter said.

The biotech-focused industrial park, which also counts GSK, Healthineers and CSL (OTC:) Behring as tenants, has been offered for sale by its owner Infrareal, they said.

Insurer Swiss Life and infrastructure investor Ancala are expected to submit binding bids in coming days, the people added.

Infrareal and Ancala were not immediately available for comment, while Swiss Life declined to comment.

Pharma-Park Marburg has annual earnings before interest, tax, depreciation and amortisation of about 25 million euros and could be valued at 400-450 million euros, the people said.

The industrial park covers an area of 67.4 hectares, and approximately 6,000 employees work there.

($1 = 0.8481 euros)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Most Related Links :
Business News Governmental News Finance News

Need Your Help Today. Your $1 can change life.

[charitable_donation_form campaign_id=57167]

Source link

Back to top button